Initializing Vogelview...
Performing medical cross-referencing...
Initializing Vogelview...
Performing medical cross-referencing...
Loading...
Also reported in: IU/mL
Your anti-CCP is negative. This is the normal and reassuring result for rheumatoid arthritis surveillance.
No anti-CCP antibodies were detected. Anti-CCP is the most specific blood test for rheumatoid arthritis with specificity over 95%. A negative result makes RA less likely and is particularly reassuring.
No action needed. If RA is still clinically suspected, seronegative RA is possible — joint symptoms should still be evaluated clinically.
Anti-CCP: negative — no anti-citrullinated protein antibodies detectedYour anti-CCP is negative and within the normal reference range. This is a very reassuring result for rheumatoid arthritis. Anti-CCP can be positive years before RA symptoms develop.
No action needed.
Anti-CCP: negative — within reference range; low RA riskYour anti-CCP is at a low-negative level with no clinically significant RA-specific antibody.
No action needed.
Anti-CCP: low-negative — no significant RA-specific antibodyYour anti-CCP is negative. This is the normal and reassuring result for rheumatoid arthritis surveillance.
No specific action required.
Anti-CCP: negative — normal baseline; RA-specific antibody absentYour anti-CCP is in the optimal range with no detectable rheumatoid arthritis-specific antibody. This is the best baseline result for joint autoimmune health.
No action needed.
Anti-CCP: optimal — undetectable RA-specific antibodyYour anti-CCP is in the borderline-positive range. Anti-CCP can be positive years before clinical RA develops. At this level, you may be in the pre-clinical phase of RA. Clinical evaluation of joints and inflammatory markers is important.
Seek rheumatology consultation. Joint examination, inflammatory markers (ESR, CRP), and repeat anti-CCP testing should be arranged. Early intervention can prevent progressive joint damage.
Anti-CCP 20–39 U/mL — borderline positive; early RA development possible; monitoring requiredYour anti-CCP is clearly positive. A positive anti-CCP antibody is highly specific for rheumatoid arthritis and is one of the ACR criteria for RA diagnosis. Higher anti-CCP levels are associated with more aggressive joint disease, greater erosive damage, and more noticeable disability if untreated.
Seek rheumatology referral. Early treatment with disease-modifying antirheumatic drugs (DMARDs) noticeably reduces joint erosion and long-term disability. Do not delay specialist evaluation.
Anti-CCP ≥40 U/mL — positive; high risk for current or future rheumatoid arthritisYour anti-CCP is very high, which is strongly associated with aggressive positive on a blood antibody test rheumatoid arthritis. Very high anti-CCP titers predict rapid joint erosion, systemic inflammation, and increased risk of extra-articular manifestations. Urgent treatment is needed to prevent irreversible joint destruction.
Seek urgent rheumatology evaluation. Early aggressive DMARD therapy is medically indicated. Joint imaging (X-ray, MRI, ultrasound) should be arranged to assess current damage.
Anti-CCP >200 U/mL — very high; highly seropositive RA; aggressive disease course likelyUpload your lab report and get your actual values interpreted in plain English — instantly, with no medical training required.